1. In this study the effect of a blend of essential oils (EO) comprising 15 g/tonne thymol and 5 g/tonne cinnamaldehyde on the performance and intestinal microbiota of broilers was investigated. 2. A total of 720 male Ross broilers were divided into two dietary treatments with 12 replicate pens per treatment. Broilers were given a control soybean-wheat-based diet with or without added EO in two diet phases (0-21 d and 22-42 d). 3. The blend of EO increased body weight gain of broilers from 0 to 42 d by 45%. 4. Caecal microbiota were affected by the EO blend; in particular increases in the proportions of Lactobacillus and Escherichia coli at 41 d was observed. 5. The EO blend had major effects on caecal metabolites. The proportion of caecal butyrate at 20 and 41 d of age increased, whereas the proportion of caecal acetic acid at 20 d, and propionic acid and isovaleric acid at 41 d, decreased with the EO blend. In addition, the caecal proportion of spermine increased and tyramine decreased at 41 d of age with the EO treatment. 6. The present study shows that EO supplementation exerts a positive effect on intestinal microbiota with a concomitant enhancement in growth performance. The study suggests that modulation of broiler gut microbiota composition and activity through the administration of EO offers an effective means for improving broiler performance.
Inulin is a well-known fructose-based prebiotic which has been shown to stimulate the growth of bifidobacteria, a bacterial group generally considered beneficial for intestinal health. In the present study, we analyzed inulin-associated shifts in the total bacterial community of wild-type mice and mice carrying a genetically inactivated adenomatous polyposis coli tumor suppressor gene by using DNA-based approaches independent of bacterial culturability. Mice were fed a high-fat, nonfiber diet with or without inulin inclusion at a 10% (wt/wt) concentration. Cecal contents were analyzed after 0, 3, and 9 weeks on the experimental diets. Inulin inclusion significantly affected the total bacterial community structure of the cecum as determined by both a nonselective percent-guanine-plus-cytosine-based profiling analysis and a more specific 16S ribosomal DNA sequence analysis. The shifts included stimulation of bifidobacteria and suppression of clostridia, but sequence comparison revealed that the major shifts were within previously unknown bacterial taxa. Concomitantly, significantly higher bacterial densities, determined by flow cytometry, were observed with the inulin-amended diet, and the metabolism of the cecal bacterial community was altered, as indicated by higher levels of residual short-chain fatty acids, particularly lactic acid. With regard to all of the microbiological parameters measured, the wild-type mice and mice carrying a genetically inactivated adenomatous polyposis coli tumor suppressor gene were essentially identical. Studies of the implications of pre-and probiotics may need to be expanded to include careful analysis of their effects on the entire microbial community, rather than just a few well-known species. Further studies are needed to increase our understanding of the possible roles of currently unknown gastrointestinal bacteria in health and disease.
ABSTRACT:The use of antimicrobial growth promoters has been banned in the EU. This has created an interest in alternative strategies to prevent an imbalance in the intestinal microbiota and the potential development of intestinal disorders in livestock. Essential oils (EOs) have been known to exhibit antimicrobial activity against specific microbial species and could therefore be considered one such alternative in controlling the intestinal microbial population. Under anaerobic conditions, the tested Clostridium perfringens strains were found to be sensitive (P < 0.05) to carvacrol, cinnamaldehyde, citral, limonene, thymol, particularly at the higher concentration tested (500 mg/l) and to oregano oil, rosemary oil and thyme oil. Streptococcus epidermis was sensitive (P < 0.05) to most EO's tested, also mainly at the higher concentration. The tested Salmonella serovars were found to be sensitive (P < 0.05) only to high (500 mg/l) concentrations of the tested EOs. Escherichia coli was sensitive (P < 0.05) to most of the tested EOs, also at lower concentrations (5 and 50 mg/l). Bifidobacterium longum, Bifidobacterium breve and Lactobacillus reuteri were less sensitive (P < 0.05) to most of the tested EOs, while Bifidobacterium animalis ssp. lactis and L. fermentum were relatively sensitive also at lower concentrations (5 and 50 mg/l), although growth reduction by EOs of these bacterial species was less then with the antimicrobial growth promoter avilamycin. With the exception of Salmonella and E. coli, all tested microbes were sensitive to avilamycin. Selected EOs seem to have the advantage of inhibiting the growth of potential pathogens while only moderately influencing beneficial members of the intestinal microbiota. This difference in sensitivity may strengthen the microbiota and contribute to improved animal health.
Betaine and its precursor choline were compared in their efficiency in affecting the performance, carcass traits, and liver betaine concentration of growing-finishing pigs. Individually penned Finnish Landrace and Yorkshire pigs and their crosses (30 kg; no. = 70) were offered the basal diet with no added betaine or choline, or the basal diet supplemented with low to moderate doses (250, 500 or 1000 mg/kg) of betaine (Betafin® S1), or with a similar molar amount of choline (578, 1155 or 2310 mg/kg of choline chloride). The maize-soya-bean-meal basal diet was formulated to contain 12·3 MJ/kg digestible energy, 155 g/kg crude protein and 7·4, 4·4 and 4·3 g/kg digestible lysine, threonine and methionine + cystine, respectively. Oat hull meal (100 g/kg) was added to reduce the dietary energy concentration. The pigs were on a restricted feeding level, 1·5 to 3·0 kg food per day (proportionately 0·8 of ad libitum intake) for 75 days. Daily weight gain and food-to-gain ratio improved linearly (P < 0·01) with increasing dietary betaine. Carcass weight increased linearly (P < 0·01) but slaughter loss proportion, backfat and sidefat thicknesses and lean proportions in ham and carcass were unaffected by dietary betaine level. Liver betaine level increased linearly (by up to a proportion of 0·62 in comparison with the control) with dietary betaine addition (F < 0·05) and betaine tended to improve linearly the tensile strength of the proximal ileum (P = 0·07). The presence of choline had no effect on any of these parameters. These results indicate that low to moderate doses of dietary betaine improved the growth and the efficiency of food utilization of growing-finishing pigs. Pigs on betaine diets had heavier carcasses without a relative increase in carcass fat. Choline had no such effects in pigs offered the restricted amount of diet. Liver betaine concentration increased with level of betaine in the diet whereas the betaine precursor choline did not affect hepatic betaine.
The sequestration/inactivation of the oestrogenic mycotoxin zearalenone (ZEA) by two adsorbents--yeast cell wall extract (YCW) and hydrated sodium calcium aluminosilicate (HSCAS)--was studied in three laboratory models: (1) an in vitro model was adapted from referenced methods to test for the sequestrant sorption capabilities under buffer conditions at two pH values using liquid chromatography coupled to a fluorescence detector for toxin quantification; (2) a second in vitro model was used to evaluate the sequestrant sorption stability according to pH variations and using ³H-labelled ZEA at low toxin concentration; and (3) an original, ex vivo Ussing chamber model was developed to further understand the transfer of ZEA through intestinal tissue and the impact of each sequestrant on the mycotoxin bioavailability of ³H-labelled ZEA. YCW was a more efficient ZEA adsorbent than HSCAS in all three models, except under very acidic conditions (pH 2.5 or 3.0). The Ussing chamber model offered a novel, ex vivo, alternative method for understanding the effect of sequestrant on the bioavailability of ZEA. The results showed that compared with HSCAS, YCW was more efficient in sequestering ZEA and that it reduced the accumulation of ZEA in the intestinal tissue by 40% (p < 0.001).
SummaryResin acid composition (RAC) has previously been shown to inhibit the growth of the Gram-positive bacterial species Clostridium perfringens in vitro and to modulate the ileal microbiota of broiler chickens. The following trials examined the effect of RAC on broiler chickens in two experiments. In experiment 1, 1400 one-day-old Ross 308 broilers were divided into two coccidiostat treatments: chemical (CC) and ionophore (IC), which were further divided into two RAC dosages: 0 and 0.5 g/kg. All diets were supplemented with xylanase, β-glucanase and phytase feed enzymes. The birds were raised in a commercial-type environment without additional microbial challenge during the 42-day trial. RAC improved the body weight gain by 3.3% and feed conversion ratio by 5.7% with CC, and improved footpad lesion scores with IC but had no effect on the litter quality. Experiment 2 was a 35-day subclinical necrotic enteritis (NE) challenge trial with 510 male Ross 308 chickens. The dietary treatments included a non-challenged, non-supplemented control and four NE challenged treatments with dietary RAC supplementation at 0, 1, 2, and 3 g/kg. The birds were challenged with Eimeria maxima on day nine and C. perfringens on day 14. While RAC at 1 g/kg significantly increased bird weight gain during the challenge, it did not affect the microbial or short chain fatty acid (SCFA) profiles. In contrast, RAC at 3 g/kg reduced the abundance of the Lactobacillus group and tended to reduce the abundance of genus Bifidobacterium and the total numbers of eubacteria. These experiments suggest that dietary RAC at a moderate dose positively affected broiler performance. However, changes in caecal microbiota populations may not have influenced the observed performance effects of RAC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.